Market Place
Sourcing Support
Intellipharmaceutics Announces Downgrade To OTC Expert Market
14 Jun 2024 //
ACCESSWIRE
Intellipharmaceutics Announces Transfer of Listing to NEX and Stock Option Plan
13 Mar 2024 //
ACCESSWIRE
Intellipharmaceutics Announces Cease Trade Order
06 Mar 2024 //
ACCESSWIRE
Intellipharmaceutics Announces Delay in Filing Audited Financial Statements
26 Feb 2024 //
ACCESSWIRE
Intellipharmaceutics International Inc. Announces Stock Option Grant
08 Feb 2024 //
ACCESSWIRE
Intellipharmaceutics Receives Conditional Approval to List on TSX Exchange
02 Jan 2024 //
ACCESSWIRE
Intellipharmaceutics Announces Third Quarter 2023 Results
16 Oct 2023 //
ACCESSWIRE
Intellipharmaceutics Reports Director Election Results
14 Sep 2023 //
ACCESSWIRE
Intellipharmaceutics Announces Second Quarter 2023 Results
14 Jul 2023 //
ACCESSWIRE
Intellipharmaceutics Announces Third Quarter 2022 Results
14 Oct 2022 //
ACCESSWIRE
Intellipharmaceutics Announces First Quarter 2022 Results
14 Apr 2022 //
ACCESSWIRE
"Intellipharmaceutics Announces That The Company And Purdue Agreement
02 Jul 2020 //
INTELLIPHARMACEUTICS
FDA committee rejects Intellipharmaceutical`s opioid drug Aximris
18 Jan 2020 //
PM LIVE
Intellipharmaceutics Provides Update on FDA Advisory Committees Meeting
16 Jan 2020 //
FINANCE YAHOO
Intellipharmaceutics` Generic Desvenlafaxine Receives Approval in US
08 Feb 2019 //
FDA
Red light for blue oxy: US FDA rejects Rexista`s anti-abuse traits
27 Sep 2017 //
IN PHARMATECHNOLOGIST
FDA declines to approve Intellipharma`s opioid painkiller
26 Sep 2017 //
REUTERS
FDA panel votes against approving Intellipharma`s opioid painkiller
26 Jul 2017 //
REUTERS
Canadian Pharma Goes Before FDA Panel Wednesday on Tamper Resistant Opioid
25 Jul 2017 //
THESTREET
FDA staff raise concerns about Intellipharma`s opioid painkiller
25 Jul 2017 //
REUTERS
Intellipharmaceutics Generic Quetiapine Fumarate Receives Approval In US
11 May 2017 //
FDA
Intellipharmaceutics Reports Director Election Results
18 Apr 2017 //
GLOBENEWSWIRE
Intellipharmaceutic Reports on Launch of Additional Strengths of Generic Focalin
06 Jan 2017 //
GLOBENEWSWIRE
Intellipharmaceutics Signs License and Commercial Supply Pact with Mallinckrodt
11 Oct 2016 //
GLOBENEWSWIRE
Intellipharmaceutics Announces FDA tentative approval for generic Seroquel XR®
07 Oct 2016 //
GLOBENEWEWIRE
Intellipharmaceutic`s Generic Levetiracetam to treat epilepsy
23 Feb 2016 //
FDA
UPDATE 1-Collegium`s painkiller gets green light from FDA panel
12 Sep 2015 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.